Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Dimopoulos

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|October 21, 2004
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, C Papadimitriou, H Linardou, et al.
Oncology|May 8, 2001
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerG Fountzilas, C Papadimitriou, G Aravantinos, et al.
Cancer Investigation|April 12, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerE Razis, A M Dimopoulos, D Bafaloukos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A M Dimopoulos, C Papadimitriou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II studyV Georgoulias, N Androulakis, A M Dimopoulos, et al.
Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2005
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00G Fountzilas, U Dafni, H Gogas, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|October 21, 2004
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, C Papadimitriou, H Linardou, et al.
Oncology|May 8, 2001
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerG Fountzilas, C Papadimitriou, G Aravantinos, et al.
Cancer Investigation|April 12, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancerE Razis, A M Dimopoulos, D Bafaloukos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, A M Dimopoulos, C Papadimitriou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II studyV Georgoulias, N Androulakis, A M Dimopoulos, et al.
Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2005
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00G Fountzilas, U Dafni, H Gogas, et al.
Pageof 2